Front-loaded treatment with a novel psoriasis drug achieved 75% disease response in more than half of patients, irrespective of prior exposure or response to biologic therapy, results of a randomized trial showed. Med Page Today. 03/07/2013. (Also see: Psoriasis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.